We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Biotech Growth Trust (the) Plc | BIOG | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 27.00 | 2.92% | 952.00 | 16:35:02 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 942.00 | 933.00 | 957.00 | 952.00 | 925.00 |
| Industry Sector |
|---|
| EQUITY INVESTMENT INSTRUMENTS |
| Top Posts |
|---|
Posted at 16/11/2022 07:54 by ali47fish biog update new chair some improvement |
Posted at 09/12/2021 11:31 by steeplejack Questor in Daily Telegraph (9 Dec) recommends BIOG after marked underperformance in 2021. |
Posted at 29/11/2021 19:03 by steeplejack Oh dear,not popular comments i see.Thing is,over the last five years,BIOG is up 57%,over the same period SMT is up 375%.Investment is about opportunity cost as we all know.Now compared with Astra or Pfizer,the underperformance is that much less,over five years the former is up 97% and the latter up 77%.(Generously,i |
Posted at 28/7/2021 16:47 by daveoz1 Absolutely ali47fish - I did a lot of investing about 4 months ago and BIOG has been by far the worst performing fund of those that I bought then, especially in the last few days! Finding it very hard to find out reasons for this. Slightly better today, but I'm hoping it improves a LOT more! |
Posted at 16/7/2021 11:52 by tomps2 John Rosier mentions Biotech Growth (BIOG) in the latest PIWORLD interview at 12m14sWatch the video here: Or listen to the podcast here: |
Posted at 09/6/2021 07:11 by steeplejack 2.5% of BIOG portfolio represented by Biogen which jumped some 40% in the US yesterday following FDA approval of its Alzheimer drug. |
Posted at 06/3/2021 19:31 by cliff007 Ali. That's what I meant. I'm wondering what's going on. Another Investment Trust I have WWH, has suffered the same fate so I don't believe it's BIOG specific. I'm holding on..... |
Posted at 01/8/2019 16:04 by healthtech That's because IBT has a dividend yield of 4% and has outperformed its index. Seems like YTD BIOG is performing better, but need to sustain this to improve its long term performance. |
Posted at 29/7/2019 16:56 by rogerrail IBT on slight premium to NAV whereas BIOG at a discount . Very similar funds, I would expect BIOG to catch up at some point |
Posted at 28/2/2018 14:08 by andyj By the way, there is an excellent and insightful free research paper on BIOG at Edison Investment Research dated Feb 22. Sorry I cannot post the link. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
